ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for diverse ...
Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.
In this free webinar, learn how simplifying supply chain management can accelerate the advancement of CRISPR-based therapies, reduce risk and ultimately bring therapies to market faster. Attendees ...
Researchers in the U.S. are using the gene-editing technology known as CRISPR to devise a COVID-19 diagnostic test that they say could be quick, cheap and only slightly more complicated than a ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout ...
SAN DIEGO & BRISBANE, Calif.--(BUSINESS WIRE)--VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback